Jolt Health Inc.
JTHTF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -52.61% | -51.00% | 81.30% | -84.23% | 2.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -52.61% | -51.00% | 81.30% | -84.23% | 2.97% |
| Operating Income | 52.61% | 51.00% | -81.30% | 84.23% | -2.97% |
| Income Before Tax | 49.82% | 74.10% | 5.71% | 82.04% | -6.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.82% | 74.10% | 5.71% | 82.04% | -6.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.82% | 74.10% | 5.71% | 82.04% | -6.48% |
| EBIT | 52.61% | 51.00% | -81.30% | 84.23% | -2.97% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 74.90% | 87.16% | 27.50% | 82.01% | 33.59% |
| Normalized Basic EPS | 75.15% | 76.07% | -42.00% | 81.88% | 33.47% |
| EPS Diluted | 74.90% | 87.16% | 27.50% | 82.01% | 33.59% |
| Normalized Diluted EPS | 75.15% | 76.07% | -42.00% | 81.88% | 33.47% |
| Average Basic Shares Outstanding | 100.00% | 100.61% | 29.35% | 0.00% | 60.13% |
| Average Diluted Shares Outstanding | 100.00% | 100.61% | 29.35% | 0.00% | 60.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |